Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Atochem, historically known as Elf Atochem, was a major French chemical company and a subsidiary of the Elf Aquitaine group. The company played a significant role in the life sciences sector by providing specialty chemicals, pharmaceutical intermediates, and medical-grade polymers used in drug delivery and medical devices. Following a series of mergers and reorganizations within the Total group, Atochem's assets were eventually integrated into Atofina and later spun off to form Arkema. Today, the Atochem name is primarily associated with its historical legacy in fine chemicals or smaller regional entities like Atochem Organics, which continues to manufacture pharmaceutical intermediates.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Atochem.